LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

Investing.com - STAAR Surgical Company (NASDAQ:STAA)向Alcon AG (NYSE:ALC)的有争议的出售案在其最大股东采取正式步骤发起代理权争夺以阻止每股28美元的合并后进一步升级。

(Nasdaq:STAA) announced today that it filed a definitive proxy statement related to its planned merger with Alcon.

Broadwood的申请标志着首个针对Alcon交易的有组织抵制活动。在其声明中，Broadwood指控STAAR董事会与Alcon进行了"实质上排他性"的谈判，几乎没有给其他感兴趣的各方机会提出竞争性报价。

Investing.com - Stifel将STAAR Surgical (NASDAQ: STAA )的评级从买入下调至持有，同时将目标价从20.00美元上调至28.00美元，此举是在Alcon宣布收购该公司后做出的。过去一周，STAAR股价已上涨超过50%， InvestingPro 数据显示该股目前处于超买区域。

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with ...

In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its ...

Broadwood Partners said today that it intends to vote against the proposed acquisition of Staar Surgical (Nasdaq:STAA) by Alcon (NYSE:ALC).

Investing.com - STAAR Surgical Company (NASDAQ:STAA)即将被Alcon Inc.

Part of Alcon's motivations for continuing to pursue the lawsuit relates to an upcoming TV series based on the movie. The company expressed that it wants to distance itself from Tesla and Elon Musk.